Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

31: FDA Rejects Over-the-Counter Sales of Morning-After Pills

The FDA's decision against over-the-counter sales of morning-after contraceptive Plan B has drawn significant criticism from health experts.

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

In May the Food and Drug Administration overruled its science advisers and withheld approval for over-the-counter sales of a morning-after contraceptive known as Plan B. The decision outraged many health care professionals. “It is morally repugnant, a tragedy for American women, and a stain on the reputation of an agency that calls itself ‘evidence based,’ ” says Vivian Dickerson, president of the American College of Obstetricians and Gynecologists. “Accidents happen, coercion happens, and there is a public-health imperative not to hold women hostage by hampering them from timely access to postcoital contraception.” Joining the chorus of criticism, the American Medical Association passed a resolution at its annual convention urging physicians to circumvent the ruling by giving patients advance prescriptions for the contraceptive.

Plan B is an emergency backup step when traditional birth-control methods—condoms, pills, diaphragms, IUDs—are forgotten, break, or slip out. It consists of two pills, ingested 12 hours apart, ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles